Market Place
Sourcing Support
Kuros Biosciences Expands into Extremities Markets
19 Nov 2024 //
ACCESSWIRE
Kuros Reports 149% Increase In Direct MagnetOs Sales
10 Oct 2024 //
ACCESSWIRE
Kuros Biosciences Reports First Half of 2024 Results
08 Aug 2024 //
ACCESSWIRE
Kuros Reports Q1 Highlights, Increased MagnetOs Sales
24 Apr 2024 //
ACCESSWIRE
Annual General Meeting of Kuros Biosciences Approves All Resolutions
17 Apr 2024 //
ACCESSWIRE
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
01 Feb 2024 //
ACCESSWIRE
Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules
31 Jan 2024 //
ACCESSWIRE
Kuros Bio Announces Three Advancements Related to its MagnetOsTM Portfolio
04 Jan 2024 //
ACCESSWIRE
Kuros Bio Announces Results from Two Prospective Trials: STRUCTURE and MAXA
27 Dec 2023 //
ACCESSWIRE
Kuros Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages
28 Nov 2023 //
ACCESSWIRE
Kuros Reports a 150% Increase in MagnetOs Sales in the First Nine Months of 2023
12 Oct 2023 //
ACCESSWIRE
Kuros Biosciences Reports Results for First Half 2023
09 Aug 2023 //
ACCESSWIRE
Kuros Biosciences completes enrolment in Level 1 clinical study
02 Nov 2022 //
PHARMIWEB
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.